Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Damora Therapeutics, Inc. DMRA

Set alert

Price alert · DMRA

All alert types
22.45 USD +0.85 +3.92%

As of Nov 3, 10:22 AM ET

Bid
22.42 × 2
Ask
22.64 × 1
21.76 Day range 22.60
4.95 52-week range 38.33
YTD
-2.45%
1 year
+235.01%
Open
21.76
Prev close
21.60
Mkt cap
1.39B
Vol
23.02K
Avg vol
530.38K
EPS
-0.25
P/E
0.00
Div yield
0.00%
More statistics
Low
21.76
High
22.60
Forward P/E
-9.94
Beta
1.51
Short ratio
6.65
Inst. own
105.85%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
23.53
200-d avg
25.66
1y target
46.89

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for DMRA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

28.17 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -0.2×
FY 2018: -20.1×FY 2019: -9.1×FY 2020: -9.1×FY 2021: -1.5×FY 2022: -0.5×FY 2023: -0.5×FY 2024: -0.3×FY 2025: -0.2×
FY 2018 5y median -0.5× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.1×
FY 2018: 12.4×FY 2019: 7.9×FY 2020: 1.9×FY 2021: 0.7×FY 2022: 0.5×FY 2023: 0.6×FY 2024: 0.4×FY 2025: 0.1×
FY 2018 5y median 0.5× FY 2025
P/FCF -4.7×
FY 2018: -27.9×FY 2019: -19.7×FY 2020: -8.3×FY 2021: -1.5×FY 2022: -0.7×FY 2023: -0.5×FY 2024: -0.3×FY 2025: -4.7×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA 1.1×
FY 2018: -27.2×FY 2019: -9.5×FY 2020: -4.6×FY 2021: -0.3×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.3×FY 2025: 1.1×
FY 2018 5y median 0.1× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -21.4%
FY 2018: -3.6%FY 2019: -5.1%FY 2020: -12.1%FY 2021: -68.6%FY 2022: -147.6%FY 2023: -192.9%FY 2024: -346.1%FY 2025: -21.4%
FY 2018 5y median -147.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -87.3%
FY 2018: -51.8%FY 2019: -75.3%FY 2020: -21.1%FY 2021: -44.1%FY 2022: -99.8%FY 2023: -118.6%FY 2024: -148.2%FY 2025: -87.3%
FY 2018 5y median -99.8% FY 2025
ROIC -87.7%
FY 2018: -42.1%FY 2019: -79.9%FY 2020: -20.2%FY 2021: -44.2%FY 2022: -97.8%FY 2023: -111.9%FY 2024: -106.0%FY 2025: -87.7%
FY 2018 5y median -97.8% FY 2025
ROA -80.5%
FY 2018: -45.2%FY 2019: -64.5%FY 2020: -20.3%FY 2021: -42.3%FY 2022: -84.2%FY 2023: -100.3%FY 2024: -125.1%FY 2025: -80.5%
FY 2018 5y median -84.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income -1148.0%
FY 2018: 0.0%FY 2019: -201.9%FY 2020: 13.7%FY 2021: -55.3%FY 2022: -17.2%FY 2023: 40.4%FY 2024: 53.7%FY 2025: -1148.0%
FY 2018 FY 2025
EPS (diluted) -725.6%
FY 2018: 0.0%FY 2019: -121.4%FY 2020: 16.6%FY 2021: -48.5%FY 2022: -18.4%FY 2023: 40.5%FY 2024: 48.6%FY 2025: -725.6%
FY 2018 FY 2025
Free Cash Flow 63.9%
FY 2018: 0.0%FY 2019: -41.2%FY 2020: -97.7%FY 2021: -37.5%FY 2022: 17.9%FY 2023: 14.4%FY 2024: 49.5%FY 2025: 63.9%
FY 2018 FY 2025

Financial Health

Current Ratio 13.0×
FY 2018: 7.9×FY 2019: 7.1×FY 2020: 30.4×FY 2021: 24.2×FY 2022: 5.8×FY 2023: 6.3×FY 2024: 14.1×FY 2025: 13.0×
FY 2018 5y median 13.0× FY 2025
Quick Ratio 13.0×
FY 2018: 7.9×FY 2019: 7.1×FY 2020: 30.4×FY 2021: 24.2×FY 2022: 5.8×FY 2023: 6.3×FY 2024: 14.1×FY 2025: 13.0×
FY 2018 5y median 13.0× FY 2025
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2018: 2.4×FY 2019: 0.3×FY 2020: 4.9×FY 2021: 1.2×FY 2022: 0.5×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 1.2×
FY 2018 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2018: -4.3×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31